LusoBioMaker: A low-cost 3D bioprinter with multi-extrusion and contour printing capabilities for thermo- and photocurable hydrogels towards complex tissue fabrication
{"title":"LusoBioMaker: A low-cost 3D bioprinter with multi-extrusion and contour printing capabilities for thermo- and photocurable hydrogels towards complex tissue fabrication","authors":"Afonso Gusmão , Diana M.C. Marques , Duarte Almeida , Kristin Schüler , Frederico Castelo Ferreira , Paola Sanjuan-Alberte , Marco Leite","doi":"10.1016/j.bprint.2025.e00425","DOIUrl":null,"url":null,"abstract":"<div><div>3D bioprinting is an expanding field that allows for the design of intricate structures using multiple materials and living cells. This has enormous potential for applications in drug testing, regenerative medicine, and, more recently, cell-based food products, with the surge of the cellular agriculture field. However, the high cost of equipment is frequently a significant limitation for implementing these approaches. Here, we present LusoBioMaker, an open-source bioprinter that delivers commercial-grade performance for under $900 of materi. Built on a modified Ender 3-V2 platform it integrates dual screw-driven extrusion, independent active temperature control (2–50 °C) and in-situ 365 nm photocuring, generating up to 320 N force through open-access firmware. Using κ-carrageenan, Pluronic F-127 and gelatin methacrylate/poly(ethyleneglycol) diacrylate (GelMA/PEGDA) inks we printed complex lattices with a printability factor of 0.995 and sub-millimetre dimensional errors while maintaining 97 % L929 cell viability after fourteen days. Comprehensive calibration and acceptance tests performed in accordance with the ISO 230-1/2 standards confirmed <50 μm positional error and <0.005° angular deviation across both extrusion nozzles. A systematic review of 17 reported low-cost bioprinters revealed that none combine dual screw extrusion, active thermal regulation and on-head UV curing in a single chassis, highlighting LusoBioMaker's unique features set. As a proof-of-concept, we bioprinted a hollow nipple–areola complex by co-extruding a thermosensitive κ-carrageenan core and a photocurable GelMA/PEGDA shell, exploiting all three hardware capabilities in one uninterrupted run. This demonstration underscores LusoBioMaker's capacity to manufacture anatomically intricate, gradient tissues on demand and to democratise advanced biofabrication workflows.</div></div>","PeriodicalId":37770,"journal":{"name":"Bioprinting","volume":"50 ","pages":"Article e00425"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioprinting","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405886625000417","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Computer Science","Score":null,"Total":0}
引用次数: 0
Abstract
3D bioprinting is an expanding field that allows for the design of intricate structures using multiple materials and living cells. This has enormous potential for applications in drug testing, regenerative medicine, and, more recently, cell-based food products, with the surge of the cellular agriculture field. However, the high cost of equipment is frequently a significant limitation for implementing these approaches. Here, we present LusoBioMaker, an open-source bioprinter that delivers commercial-grade performance for under $900 of materi. Built on a modified Ender 3-V2 platform it integrates dual screw-driven extrusion, independent active temperature control (2–50 °C) and in-situ 365 nm photocuring, generating up to 320 N force through open-access firmware. Using κ-carrageenan, Pluronic F-127 and gelatin methacrylate/poly(ethyleneglycol) diacrylate (GelMA/PEGDA) inks we printed complex lattices with a printability factor of 0.995 and sub-millimetre dimensional errors while maintaining 97 % L929 cell viability after fourteen days. Comprehensive calibration and acceptance tests performed in accordance with the ISO 230-1/2 standards confirmed <50 μm positional error and <0.005° angular deviation across both extrusion nozzles. A systematic review of 17 reported low-cost bioprinters revealed that none combine dual screw extrusion, active thermal regulation and on-head UV curing in a single chassis, highlighting LusoBioMaker's unique features set. As a proof-of-concept, we bioprinted a hollow nipple–areola complex by co-extruding a thermosensitive κ-carrageenan core and a photocurable GelMA/PEGDA shell, exploiting all three hardware capabilities in one uninterrupted run. This demonstration underscores LusoBioMaker's capacity to manufacture anatomically intricate, gradient tissues on demand and to democratise advanced biofabrication workflows.
期刊介绍:
Bioprinting is a broad-spectrum, multidisciplinary journal that covers all aspects of 3D fabrication technology involving biological tissues, organs and cells for medical and biotechnology applications. Topics covered include nanomaterials, biomaterials, scaffolds, 3D printing technology, imaging and CAD/CAM software and hardware, post-printing bioreactor maturation, cell and biological factor patterning, biofabrication, tissue engineering and other applications of 3D bioprinting technology. Bioprinting publishes research reports describing novel results with high clinical significance in all areas of 3D bioprinting research. Bioprinting issues contain a wide variety of review and analysis articles covering topics relevant to 3D bioprinting ranging from basic biological, material and technical advances to pre-clinical and clinical applications of 3D bioprinting.